West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
West Pharmaceutical Services (NYSE: WST) announced its participation at CPHI Worldwide in Milan, Italy, showcasing its leadership in packaging and containment solutions for injectable drug administration. The company will present on Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1 revisions, highlighting the critical role of quality control in drug manufacturing.
West is also a finalist for a CPHI Award in the 'Heart of Pharma' category for its partnership with Fox Chase Cancer Center, recognizing philanthropic and community-based initiatives. The awards ceremony will take place on October 8, the opening night of CPHI.
Cindy Reiss-Clark, Chief Commercial Officer at West, emphasized the importance of third-party suppliers' quality control in maintaining a robust contamination control strategy for drug manufacturers.
West Pharmaceutical Services (NYSE: WST) ha annunciato la sua partecipazione a CPHI Worldwide a Milano, Italia, mostrando il suo leadership nelle soluzioni di packaging e contenimento per la somministrazione di farmaci iniettabili. L'azienda presenterà sulla Strategia di Controllo della Contaminazione nel Packaging Primario come parte delle revisioni dell'Allegato 1 delle GMP dell'UE, evidenziando il ruolo cruciale del controllo qualità nella produzione di farmaci.
West è anche finalista per un premio CPHI nella categoria 'Heart of Pharma' per la sua collaborazione con il Fox Chase Cancer Center, riconoscendo iniziative filantropiche e orientate alla comunità. La cerimonia di premiazione avrà luogo l'8 ottobre, la serata di apertura del CPHI.
Cindy Reiss-Clark, Chief Commercial Officer di West, ha sottolineato l'importanza del controllo qualità dei fornitori terzi nel mantenere una robusta strategia di controllo della contaminazione per i produttori di farmaci.
West Pharmaceutical Services (NYSE: WST) anunció su participación en CPHI Worldwide en Milán, Italia, mostrando su liderazgo en soluciones de envasado y contención para la administración de medicamentos inyectables. La empresa presentará sobre la Estrategia de Control de Contaminación en el Empaque Primario como parte de las revisiones del Anexo 1 de GMP de la UE, destacando el papel crítico del control de calidad en la fabricación de medicamentos.
West también es finalista para un premio CPHI en la categoría 'Heart of Pharma' por su colaboración con el Fox Chase Cancer Center, reconociendo iniciativas filantrópicas y basadas en la comunidad. La ceremonia de premiación tendrá lugar el 8 de octubre, en la noche inaugural de CPHI.
Cindy Reiss-Clark, Directora Comercial de West, enfatizó la importancia del control de calidad de los proveedores externos para mantener una sólida estrategia de control de contaminación para los fabricantes de medicamentos.
West Pharmaceutical Services (NYSE: WST)는 이탈리아 밀라노에서 개최되는 CPHI Worldwide에 참가하여 주사제 투여를 위한 포장 및 억제 솔루션에서의 리더십을 선보였습니다. 이 회사는 EU GMP 부록 1의 수정 사항의 일환으로 1차 포장 내 오염 통제 전략에 대해 발표하며, 의약품 제조에서 품질 관리의 중요한 역할을 강조할 것입니다.
West는 또한 Fox Chase Cancer Center와의 파트너십으로 'Heart of Pharma' 부문에서 CPHI Award의 결선 진출자입니다. 이는 자선 및 지역사회 기반의 이니셔티브를 인정받는 것입니다. 시상식은 CPHI의 개막 밤인 10월 8일에 열릴 예정입니다.
West의 Chief Commercial Officer인 Cindy Reiss-Clark는 의약품 제조업체들을 위한 단단한 오염 통제 전략을 유지하기 위해 제3자 공급업체의 품질 관리가 중요하다고 강조했습니다.
West Pharmaceutical Services (NYSE: WST) a annoncé sa participation à CPHI Worldwide à Milan, en Italie, mettant en avant son leadership dans les solutions d'emballage et de confinement pour l'administration de médicaments injectables. L'entreprise présentera sur la Stratégie de Contrôle de Contamination dans l'Emballage Primaire dans le cadre des révisions de l'Annexe 1 des BPF de l'UE, soulignant le rôle crucial du contrôle qualité dans la fabrication des médicaments.
West est également finaliste d'un prix CPHI dans la catégorie 'Heart of Pharma' pour son partenariat avec le Fox Chase Cancer Center, reconnaissant les initiatives philanthropiques et communautaires. La cérémonie de remise des prix aura lieu le 8 octobre, lors de la soirée d'ouverture de CPHI.
Cindy Reiss-Clark, Directrice Commerciale de West, a souligné l'importance du contrôle qualité des fournisseurs tiers pour maintenir une stratégie de contrôle de contamination solide pour les fabricants de médicaments.
West Pharmaceutical Services (NYSE: WST) gab seine Teilnahme an CPHI Worldwide in Mailand, Italien, bekannt, wo das Unternehmen seine Führungsposition im Bereich Verpackungs- und Containment-Lösungen für die Verabreichung injizierbarer Medikamente demonstriert. Das Unternehmen wird über die Kontrollstrategie zur Kontamination in der Primärverpackung im Rahmen der Überarbeitungen des EU GMP Anhangs 1 berichten und die entscheidende Rolle der Qualitätskontrolle in der Arzneimittelherstellung hervorheben.
West ist außerdem Finalist für einen CPHI Award in der Kategorie 'Heart of Pharma' für die Partnerschaft mit dem Fox Chase Cancer Center, die philanthropische und gemeinschaftsorientierte Initiativen anerkennt. Die Preisverleihung findet am 8. Oktober, der Eröffnungsnacht von CPHI, statt.
Cindy Reiss-Clark, Chief Commercial Officer von West, betonte die Bedeutung der Qualitätskontrolle von Drittanbietern zur Aufrechterhaltung einer soliden Kontaminationskontrollstrategie für Arzneimittelhersteller.
- None.
- None.
This year, West will highlight its industry expertise through a technical-focused presentation:
- Examining Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1- Wednesday, October 9 | 2:15 - 2:40 p.m.
- Presented by Ana Kuschel, Principal, Scientific Affairs, West
"The revisions to EU GMP Annex 1 represent a significant shift in drug manufacturing with over 30 references to primary packaging alone," said Cindy Reiss-Clark, Chief Commercial Officer at West. "At West, we know a drug manufacturer's contamination control strategy is only as strong as its weakest link, making the quality and control of materials from third party suppliers' critical factors to their process."
West is also a finalist for a CPHI Award in the "Heart of Pharma" category for its partnership with Fox Chase Cancer Center. This award recognizes companies, individuals and initiatives which nurture philanthropic, ethical and community-based ventures. Winners will be announced during the awards ceremony on the opening night of CPHI on October 8.
For more information about West, please visit our website: www.westpharma.com.
For more information about CPHI Worldwide, please visit: CPHI Milan
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-attend-and-showcase-industry-leadership-in-packaging-and-containment-at-cphi-worldwide-conference-302268066.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What event is West Pharmaceutical Services (WST) participating in?
What topic will West Pharmaceutical Services (WST) present at CPHI Worldwide?
For which award is West Pharmaceutical Services (WST) a finalist at CPHI Worldwide?
When will the CPHI Award winners be announced?
